These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
729 related articles for article (PubMed ID: 30355656)
1. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC). Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656 [TBL] [Abstract][Full Text] [Related]
2. Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs. Zhang B; Wang H; Guo Z; Zhang X J Cell Physiol; 2019 Aug; 234(10):18781-18791. PubMed ID: 30927266 [TBL] [Abstract][Full Text] [Related]
3. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma. Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476 [TBL] [Abstract][Full Text] [Related]
4. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
5. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis. Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351 [TBL] [Abstract][Full Text] [Related]
6. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma. Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459 [TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma. Guo YZ; Sun HH; Wang XT; Wang MT J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811 [TBL] [Abstract][Full Text] [Related]
9. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980 [TBL] [Abstract][Full Text] [Related]
11. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
12. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
15. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma. Wang J; Bian Q; Liu J; Moming A Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450 [TBL] [Abstract][Full Text] [Related]
16. Expression and function of long non-coding RNAs in head and neck squamous cell carcinoma. Ghafouri-Fard S; Mohammad-Rahimi H; Jazaeri M; Taheri M Exp Mol Pathol; 2020 Feb; 112():104353. PubMed ID: 31812485 [TBL] [Abstract][Full Text] [Related]
17. A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients. Jiang H; Ma B; Xu W; Luo Y; Wang X; Wen S; Liao T; Lu Z; Yang S; Wang Y Ann Surg Oncol; 2021 Jun; 28(6):3396-3406. PubMed ID: 33095358 [TBL] [Abstract][Full Text] [Related]
18. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma. Zhou M; Zhang Z; Zhao H; Bao S; Sun J BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762 [TBL] [Abstract][Full Text] [Related]
19. Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma. Diao P; Song Y; Ge H; Wu Y; Li J; Zhang W; Wang Y; Cheng J J Cell Biochem; 2019 Jun; 120(6):10010-10020. PubMed ID: 30548328 [TBL] [Abstract][Full Text] [Related]
20. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis. Hu Y; Guo G; Li J; Chen J; Tan P Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]